Keyphrases
Brain Connectivity
100%
Multiple Sclerosis
100%
Ballet
100%
Motor Improvement
100%
Connectivity Improvement
100%
Relapsing-remitting multiple Sclerosis
57%
Resting-state Functional Connectivity (rs-FC)
57%
Structural Connectivity
28%
Mean Clustering
28%
Ataxia
28%
International Cooperative Ataxia Rating Scale (ICARS)
28%
Mean Strength
28%
Clustering Coefficient
28%
Research Reporting
28%
Competing Interests
28%
Connectivity States
28%
Imaging Data
14%
Network Analysis
14%
Functional Networks
14%
Detecting Change
14%
Magnetic Resonance Imaging Data
14%
Network Change
14%
Clinical Improvement
14%
Trial Registration
14%
Network Research
14%
Ethical Guidelines
14%
Randomized Controlled Clinical Trial
14%
Expanded Disability Status Scale
14%
Symbol Digit Modalities Test
14%
Neurological Improvement
14%
Institutional Forms
14%
Reporting Guidelines
14%
Graph Measures
14%
Smoothness Indicator
14%
All Clinical Trials
14%
Ethics Committees
14%
International Committee of Medical Journal Editors (ICMJE)
14%
Prospective Interventional Study
14%
EQUATOR Network
14%
Oversight Bodies
14%
Reporting Checklist
14%
IRB Approval
14%
Mini-BESTest
14%
Functional Neurological Disorder
14%
Medicine and Dentistry
Multiple Sclerosis
100%
Ataxia
80%
Functional Connectivity
80%
Rating Scale
40%
Magnetic Resonance Imaging
20%
Clinical Trial
20%
Drug Therapy
20%
Checklist
20%
Prospective Study
20%
Controlled Clinical Trial
20%
Expanded Disability Status Scale
20%
Symbol Digit Modalities Test
20%
Neuroscience
Relapsing Remitting Multiple Sclerosis
100%
Multiple Sclerosis
100%
Resting-State Functional Connectivity
100%
Ataxia
100%
Magnetic Resonance Imaging
25%
Expanded Disability Status Scale
25%
Nursing and Health Professions
Multiple Sclerosis
100%
Ataxia
80%
Practice Guideline
40%
Rating Scale
40%
Imaging
20%
Nuclear Magnetic Resonance Imaging
20%
Drug Therapy
20%
Pilot Study
20%
Checklist
20%
Expanded Disability Status Scale
20%
Symbol Digit Modalities Test
20%
Professional Standard
20%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Sclerosis
100%
Ataxia
80%
Clinical Trial
20%
Prospective Study
20%
Expanded Disability Status Scale
20%
Controlled Clinical Trial
20%